Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

iRhythm Holdings, Inc. (IRTC)

Rosenbaum Marc Wade — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
417
Price
$128.45
Total Value
$53.56K
Shares Held After
16,706
% of Holdings
2.4%

iRhythm Holdings, Inc. (IRTC)

Rosenbaum Marc Wade — Chief Accounting Officer
Mar 2, 2026
Sale
Shares
399
Price
$128.45
Total Value
$51.25K
Shares Held After
17,123
% of Holdings
2.3%

iRhythm Holdings, Inc. (IRTC)

Patterson Chad — CHIEF COMM & PRODUCT OFFICER
Mar 2, 2026
Sale
Shares
3,030
Price
$128.44
Total Value
$389.19K
Shares Held After
58,164
% of Holdings
5.0%

iRhythm Holdings, Inc. (IRTC)

Patterson Chad — CHIEF COMM & PRODUCT OFFICER
Mar 2, 2026
Sale
Shares
1,414
Price
$128.44
Total Value
$181.62K
Shares Held After
61,194
% of Holdings
2.3%

INTUITIVE SURGICAL INC (ISRG)

Curet Myriam — EVP & Chief Medical Officer
Mar 2, 2026
Sale
Shares
125
Price
$492.59
Total Value
$61.57K
Shares Held After
5,137
% of Holdings
2.4%

RESMED INC (RMD)

Sandercock Brett — Chief Financial Officer
Mar 2, 2026
Sale
Shares
1,000
Price
$254.30
Total Value
$254.30K
Shares Held After
84,495
% of Holdings
1.2%

ARTIVION, INC. (AORT)

Horton Amy — VP, Chief Accounting Officer
Mar 2, 2026
Sale
Shares
641
Price
$38.02
Total Value
$24.37K
Shares Held After
132,514
% of Holdings
0.5%

ARTIVION, INC. (AORT)

Mackin James P — President & CEO
Mar 2, 2026
Sale
Shares
14,911
Price
$38.02
Total Value
$566.99K
Shares Held After
848,214
% of Holdings
1.7%

ARTIVION, INC. (AORT)

Holloway Jean F — SVP, General Counsel
Mar 2, 2026
Sale
Shares
2,183
Price
$38.02
Total Value
$83.01K
Shares Held After
170,105
% of Holdings
1.3%

ARTIVION, INC. (AORT)

Stanton Marshall S. — SVP, Clinical & MD Affair
Mar 2, 2026
Sale
Shares
1,513
Price
$38.02
Total Value
$57.53K
Shares Held After
40,408
% of Holdings
3.6%

ARTIVION, INC. (AORT)

Berry Lance A — EVP, COO, CFO & Treasurer
Mar 2, 2026
Sale
Shares
5,178
Price
$38.02
Total Value
$196.89K
Shares Held After
176,269
% of Holdings
2.9%

ARTIVION, INC. (AORT)

Davis John E — Chief Commercial Officer
Mar 2, 2026
Sale
Shares
2,784
Price
$38.02
Total Value
$105.86K
Shares Held After
206,522
% of Holdings
1.3%
Mar 2, 2026
Sale
Shares
200
Price
$9.98
Total Value
$2.00K
Shares Held After
1,122,391
% of Holdings
0.0%
Mar 2, 2026
Sale
Shares
21,800
Price
$9.50
Total Value
$207.19K
Shares Held After
1,122,591
% of Holdings
1.9%

FibroBiologics, Inc. (FBLG)

Davis Jason — Chief Financial Officer
Mar 2, 2026
Purchase
Shares
70,000
Price
$0.41
Total Value
$28.97K
Shares Held After
70,000
% of Holdings
100.0%
Mar 2, 2026
Sale
Shares
19,954
Price
$81.31
Total Value
$1.62M
Shares Held After
383,803
% of Holdings
4.9%
Mar 2, 2026
Sale
Shares
23,858
Price
$81.31
Total Value
$1.94M
Shares Held After
403,757
% of Holdings
5.6%
Mar 2, 2026
Purchase
Shares
50,000
Price
$32.96
Total Value
$1.65M
Shares Held After
54,281
% of Holdings
92.1%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Mar 2, 2026
Sale
Shares
8,148
Price
$15.44
Total Value
$125.79K
Shares Held After
34,601
% of Holdings
19.1%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Mar 2, 2026
Sale
Shares
2,675
Price
$33.81
Total Value
$90.44K
Shares Held After
237,584
% of Holdings
1.1%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Mar 2, 2026
Sale
Shares
2,325
Price
$33.28
Total Value
$77.39K
Shares Held After
240,259
% of Holdings
1.0%

ENSIGN GROUP, INC (ENSG)

SMITH BARRY M — Director
Mar 2, 2026
Sale
Shares
700
Price
$213.02
Total Value
$149.11K
Shares Held After
22,852
% of Holdings
3.0%

InfuSystem Holdings, Inc (INFU)

Steele Barry G — Executive VP and CFO
Mar 2, 2026
Purchase
Shares
2,064
Price
$9.16
Total Value
$18.91K
Shares Held After
88,000
% of Holdings
2.3%

Contineum Therapeutics, Inc. (CTNM)

Lorrain Daniel S. — Chief Scientific Officer
Mar 2, 2026
Sale
Shares
4,170
Price
$15.01
Total Value
$62.59K
Shares Held After
151,882
% of Holdings
2.7%

Contineum Therapeutics, Inc. (CTNM)

Watkins Tim — CMO & Head of Development
Mar 2, 2026
Sale
Shares
3,611
Price
$15.02
Total Value
$54.22K
Shares Held After
0
% of Holdings
100.0%

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Wambeke David J. — Chief Business Officer
Mar 1, 2026
Purchase
Shares
1,000,000
Price
$0.67
Total Value
$670.40K
Shares Held After
1,000,000
% of Holdings
100.0%
Version: v26.3.33